Acidic deoxycholic acid and chenodeoxycholic acid induce interleukin-8 production through p38 mitogen-activated protein kinase and protein kinase A in a squamous epithelial model

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 5, 2013, Pages 823-828

  Shan, Jing ^a,b   Oshima, Tadayuki ^a   Fukui, Hirokazu ^a   Watari, Jiro ^a   Miwa, Hiroto ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Third People's Hospital of Chengdu   (China)

Author keywords

Air liquid interface; Chenodeoxycholic acid; Deoxycholic acid; Interleukin 8; Stratified epithelium

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEOXYCHOLIC ACID; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL COMPARTMENTALIZATION; CELL CULTURE; CYTOKINE PRODUCTION; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; ESOPHAGUS MUCOSA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRACELLULAR SIGNALING; LIQUID PHASE MICROEXTRACTION; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PH; PRIORITY JOURNAL;

EID: 84876993636     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12139     Document Type: Article

References (35)

1. Dodds WJ, Dent J, Hogan WJ etal. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N. Engl. J. Med. 1982; 307: 1547-1552.
2. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006; 101: 1900-1920, Quiz 1943.
3. Souza RF, Huo X, Mittal V etal. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009; 137: 1776-1784.
4. Isomoto H, Saenko VA, Kanazawa Y etal. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am. J. Gastroenterol. 2004; 99: 589-597.
5. Isomoto H, Wang A, Mizuta Y etal. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am. J. Gastroenterol. 2003; 98: 551-556.
6. Yoshida N, Uchiyama K, Kuroda M etal. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand. J. Gastroenterol. 2004; 39: 816-822.
7. O'Riordan JM, Abdel-latif MM, Ravi N etal. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am. J. Gastroenterol. 2005; 100: 1257-1264.
8. Oh DS, DeMeester SR, Vallbohmer D etal. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. Arch. Surg. 2007; 142: 554-559, Discussion 559-60.
9. Kandulski A, Malfertheiner P. Gastroesophageal reflux disease-from reflux episodes to mucosal inflammation. Nat. Rev. Gastroenterol. Hepatol. 2011; 9: 15-22.
10. Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999; 44: 598-602.
11. Shan J, Oshima T, Chen X, Fukui H, Watari J, Miwa H. Trypsin impaired epithelial barrier function and induced IL-8 secretion through basolateral PAR-2: a lesson from a stratified squamous epithelial model. Am. J. Physiol. Gastrointest. Liver Physiol. 2012; 303: G1105-1112.
12. Yoshida N, Imamoto E, Uchiyama K, Kuroda M, Naito Y, Mukaida N. Molecular mechanisms involved in interleukin-8 production by normal human oesophageal epithelial cells. Aliment. Pharmacol. Ther. 2006; 24: 219-226.
13. Muhlbauer M, Allard B, Bosserhoff AK etal. Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 286: G1000-1008.
14. Jenkins GJ, Harries K, Doak SH etal. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. Carcinogenesis 2004; 25: 317-323.
15. Cronin J, Alhamdani A, Griffiths AP, Baxter JN, Brown T, Jenkins GJ. In vitro and ex vivo models of extended reflux exposure demonstrate that weakly acidic mixed reflux heightens NF-kB-mediated gene expression. Dis. Esophagus 2011; 24: 360-370.
16. Oshima T, Gedda K, Koseki J etal. Establishment of esophageal-like non-keratinized stratified epithelium using normal human bronchial epithelial cells. Am. J. Physiol. Cell Physiol. 2011; 300: C1422-1429.
17. Chen X, Oshima T, Shan J, Fukui H, Watari J, Miwa H. Bile salts disrupt human esophageal squamous epithelial barrier function by modulating tight junction proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 2012; 303: G199-208.
18. Chen X, Oshima T, Tomita T etal. Acidic bile salts modulate the squamous epithelial barrier function by modulating tight junction proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 2011; 301: G203-209.
19. Kauer WK, Peters JH, DeMeester TR etal. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997; 122: 874-881.
20. Theisen J, Nehra D, Citron D etal. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids. J. Gastrointest. Surg. 2000; 4: 50-54.
21. Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995; 108: 1897-1907.
22. Capello A, Moons LM, Van de Winkel A etal. Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus. Am. J. Gastroenterol. 2008; 103: 1510-1516.
23. Hong J, Behar J, Wands J etal. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2009; 59: 170-180.
24. Pols TW, Noriega LG, Nomura M, Auwerx J, Schoonjans K. The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J. Hepatol. 2011; 54: 1263-1272.
25. Kauer WK, Stein HJ. Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease. J. Gastrointest. Surg. 2010; 14 (Suppl. 1): S9-16.
26. Looby E, Abdel-Latif MM, Athie-Morales V, Duggan S, Long A, Kelleher D. Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells. BMC Cancer 2009; 9: 190.
27. Qiao D, Stratagouleas ED, Martinez JD. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis. Carcinogenesis 2001; 22: 35-41.
28. Jiang ZR, Gong J, Zhang ZN, Qiao Z. Influence of acid and bile acid on ERK activity, PPARgamma expression and cell proliferation in normal human esophageal epithelial cells. World J. Gastroenterol. 2006; 12: 2445-2449.
29. Fitzer CJ, O'Brian CA, Guillem JG, Weinstein IB. The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis 1987; 8: 217-220.
30. Kawamata Y, Fujii R, Hosoya M etal. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 2003; 278: 9435-9440.
31. Zheng M, Zhang SJ, Zhu WZ, Ziman B, Kobilka BK, Xiao RP. Beta 2-adrenergic receptor-induced p38 MAPK activation is mediated by protein kinase A rather than by Gi or gbeta gamma in adult mouse cardiomyocytes. J. Biol. Chem. 2000; 275: 40635-40640.
32. Saxena M, Williams S, Taskén K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat. Cell Biol. 1999; 1: 305-311.
33. Snoeks L, Weber CR, Turner JR, Bhattacharyya M, Wasland K, Tumor SSD. Suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells. Infect. Immun. 2008; 76: 4677-4685.
34. Lin CH, Cheng HW, Ma HP, Wu CH, Hong CY, Chen BC. Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway. J. Biol. Chem. 2011; 286: 10483-10494.
35. Wang Y, Wang W, Wang L, Wang X, Xia J. Regulatory mechanisms of interleukin-8 production induced by tumour necrosis factor-alpha in human hepatocellular carcinoma cells. J. Cell. Mol. Med. 2011; 16: 496-506.